APA

Fayek S. A., Beshears E., Lieber R., Alvey N., Sauer A., Poirier J., Hollinger E. F., Olaitan O. K., Jensik S., Geyston J., Brokhof M. M., Hodowanec A. C., Hertl M. & Simon D. M. (20170328). Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. : Transplantation proceedings.

Chicago

Fayek S A, Beshears E, Lieber R, Alvey N, Sauer A, Poirier J, Hollinger E F, Olaitan O K, Jensik S, Geyston J, Brokhof M M, Hodowanec A C, Hertl M and Simon D M. 20170328. Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. : Transplantation proceedings.

Harvard

Fayek S. A., Beshears E., Lieber R., Alvey N., Sauer A., Poirier J., Hollinger E. F., Olaitan O. K., Jensik S., Geyston J., Brokhof M. M., Hodowanec A. C., Hertl M. and Simon D. M. (20170328). Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. : Transplantation proceedings.

MLA

Fayek S A, Beshears E, Lieber R, Alvey N, Sauer A, Poirier J, Hollinger E F, Olaitan O K, Jensik S, Geyston J, Brokhof M M, Hodowanec A C, Hertl M and Simon D M. Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. : Transplantation proceedings. 20170328.